Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S C Hui

Showing results (301-310 of 305) with videos related to

Pageof 31
Sort By:
You have reached the last page of results.This site can display upto 305 results.
ACS Central Science|June 2, 2021
Simeprevir Potently Suppresses SARS-CoV-2 Replication and Synergizes with RemdesivirHo Sing Lo, Kenrie Pui Yan Hui, Hei-Ming Lai, et al.
The New England Journal of Medicine|February 29, 2020
Clinical Characteristics of Coronavirus Disease 2019 in ChinaWei-Jie Guan, Zheng-Yi Ni, Yu Hu, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 16, 2024
SARS-CoV-2-specific CD8<sup>+</sup> T cells from people with long COVID establish and maintain effector phenotype and key TCR signatures over 2 yearsLouise C Rowntree, Jennifer Audsley, Lilith F Allen, et al.
NEJM Evidence|March 24, 2026
Sequencing of Pleural Fluid and Plasma for Tuberculous PleuritisW K Jacky Lam, Ken K P Chan, Guangya Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 2, 2025
HLA-B*15:01-positive severe COVID-19 patients lack CD8<sup>+</sup> T cell pools with highly expanded public clonotypesLouise C Rowntree, Lilith F Allen, Ruth R Hagen, et al.
Pageof 31

Showing results (301-310 of 305) with videos related to

Sort By:
Pageof 31
You have reached the last page of results.This site can display upto 305 results.
ACS Central Science|June 2, 2021
Simeprevir Potently Suppresses SARS-CoV-2 Replication and Synergizes with RemdesivirHo Sing Lo, Kenrie Pui Yan Hui, Hei-Ming Lai, et al.
The New England Journal of Medicine|February 29, 2020
Clinical Characteristics of Coronavirus Disease 2019 in ChinaWei-Jie Guan, Zheng-Yi Ni, Yu Hu, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 16, 2024
SARS-CoV-2-specific CD8<sup>+</sup> T cells from people with long COVID establish and maintain effector phenotype and key TCR signatures over 2 yearsLouise C Rowntree, Jennifer Audsley, Lilith F Allen, et al.
NEJM Evidence|March 24, 2026
Sequencing of Pleural Fluid and Plasma for Tuberculous PleuritisW K Jacky Lam, Ken K P Chan, Guangya Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 2, 2025
HLA-B*15:01-positive severe COVID-19 patients lack CD8<sup>+</sup> T cell pools with highly expanded public clonotypesLouise C Rowntree, Lilith F Allen, Ruth R Hagen, et al.
Pageof 31